Please try another search
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
Sandra L. Silberman | 65 | 2017 | Member of Clinical Advisory Board |
Filip Janku | 47 | - | Member of Clinical Advisory Board |
Emmanuel Antonarakis | - | 2020 | Member of Clinical Advisory Board |
Mark Erlander | 61 | 2013 | CEO & Director |
Rodney S. Markin | 64 | 2014 | Independent Chairman of the Board |
Gary W. Pace | 73 | 2020 | Independent Director |
Renee P. Tannenbaum | 70 | 2021 | Independent Director |
Lale White | 66 | 2020 | Independent Director |
Carlo Maria Croce | - | - | Member of Scientific Advisory Board |
Paul R. Billings | 70 | 2012 | Member of Scientific Advisory Board |
Charles R. Cantor | 79 | - | Member of Scientific Advisory Board |
Michael B. Yaffe | - | 2018 | Member of Clinical Advisory Board |
Glenn J. Bubley | - | 2018 | Member of Clinical Advisory Board |
Heinz-Josef Lenz | 62 | 2020 | Member of Clinical Advisory Board |
Alberto Bardelli | - | 2014 | Member of Scientific Advisory Board |
Brunangelo Falini | - | 2010 | Member of Scientific Advisory Board |
K. Peter Hirth | 70 | 2014 | Member of Scientific Advisory Board |
James O. Armitage | 75 | 2020 | Independent Director |
Mani Mohindru | 50 | 2021 | Independent Director |
Amer Zeidan | - | 2020 | Member of Clinical Advisory Board |
Riccardo Dalla-Favera | 70 | 2010 | Member of Scientific Advisory Board |
David Einstein | - | 2018 | Member of Clinical Advisory Board |
Adam Schayowitz | - | - | Member of Scientific Advisory Board |
Christoph Reinhard | - | - | Member of Scientific Advisory Board |
Nicholas Choong | - | 2024 | Member of the Scientific Advisory Board |
Josep Tabernero Caturla | - | - | Member of Scientific Advisory Board |
Eric Van Cutsem | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review